Liver Study Unit, Nebraska-Western Iowa Health Care System, College of Medicine, University of Nebraska Medical Center, Omaha, USA.
Alcohol Clin Exp Res. 2012 May;36(5):759-67. doi: 10.1111/j.1530-0277.2011.01681.x. Epub 2011 Dec 5.
Previous work demonstrated that the transcription factor, early growth response-1 (Egr-1), participates in the development of steatosis (fatty liver) after chronic ethanol (EtOH) administration. Here, we determined the extent to which Egr-1 is involved in fatty liver development in mice subjected to acute EtOH administration.
In acute studies, we treated both wild-type and Egr-1 null mice with either EtOH or phosphate-buffered saline (PBS) by gastric intubation. At various times after treatment, we harvested sera and livers and quantified endotoxin, indices of liver injury, steatosis, and hepatic Egr-1 content. In chronic studies, groups of mice were fed liquid diets containing either EtOH or isocaloric maltose-dextrin for 7 to 8 weeks.
Compared with controls, acute EtOH-treated mice showed a rapid, transient elevation in serum endotoxin beginning 30 minutes after treatment. One hour postgavage, livers from EtOH-treated mice exhibited a robust elevation of both Egr-1 mRNA and protein. By 3 hours postgavage, liver triglyceride increased in EtOH-treated mice as did lipid peroxidation. Acute EtOH treatment of Egr-1-null mice showed no Egr-1 expression, but these animals still developed elevated triglycerides, although significantly lower than EtOH-fed wild-type littermates. Despite showing decreased fatty liver, EtOH-treated Egr-1 null mice exhibited greater liver injury. After chronic EtOH feeding, steatosis and liver enlargement were clearly evident, but there was no indication of elevated endotoxin. Egr-1 levels in EtOH-fed mice were equal to those of pair-fed controls.
Acute EtOH administration induced the synthesis of Egr-1 in mouse liver. However, despite its robust increase, the transcription factor had a smaller, albeit significant, function in steatosis development after acute EtOH treatment. We propose that the rise in Egr-1 after acute EtOH is an hepatoprotective adaptation to acute liver injury from binge drinking that is triggered by EtOH metabolism and elevated levels of endotoxin.
先前的研究表明,转录因子早期生长反应-1(Egr-1)参与慢性乙醇(EtOH)给药后脂肪变性(脂肪肝)的发展。在这里,我们确定了 Egr-1 参与急性 EtOH 给药后小鼠脂肪肝发展的程度。
在急性研究中,我们通过胃内灌注用 EtOH 或磷酸盐缓冲盐水(PBS)处理野生型和 Egr-1 缺失型小鼠。在治疗后不同时间,采集血清和肝脏并定量内毒素、肝损伤、脂肪变性和肝 Egr-1 含量的指标。在慢性研究中,将小鼠分组喂养含有 EtOH 或等热量麦芽糊精的液体饮食 7 至 8 周。
与对照组相比,急性 EtOH 处理的小鼠在治疗后 30 分钟开始迅速、短暂地升高血清内毒素。灌胃后 1 小时,EtOH 处理的小鼠肝脏中 Egr-1 mRNA 和蛋白均显著升高。灌胃后 3 小时,EtOH 处理的小鼠肝脏甘油三酯增加,脂质过氧化也增加。急性 EtOH 处理的 Egr-1 缺失型小鼠没有 Egr-1 表达,但这些动物仍出现甘油三酯升高,尽管明显低于 EtOH 喂养的野生型同窝仔鼠。尽管 Egr-1 缺失型小鼠的脂肪肝程度降低,但肝脏损伤更大。慢性 EtOH 喂养后,明显可见脂肪变性和肝脏肿大,但内毒素水平没有升高。EtOH 喂养的小鼠的 Egr-1 水平与配对喂养的对照组相同。
急性 EtOH 给药诱导了小鼠肝脏中 Egr-1 的合成。然而,尽管 Egr-1 显著增加,但该转录因子在急性 EtOH 治疗后脂肪变性的发展中仅发挥较小但显著的作用。我们提出,急性 EtOH 后 Egr-1 的增加是一种肝保护适应,可防止由 EtOH 代谢和内毒素水平升高引起的 binge 饮酒导致的急性肝损伤。